NCT00996086View on ClinicalTrials.gov

Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)

CompletedOBSERVATIONAL
Enrollment

154

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Heart FailureVentricular Arrhythmias
Interventions
DEVICE

CRT device implant

CRT device-recipients

Trial Locations (2)

10010

Touro College, New York

15240

Veterans' Adminstration Pittsburgh Healthcare System, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Northwestern University

OTHER

collaborator

VA Pittsburgh Healthcare System

FED

lead

Abbott Medical Devices

INDUSTRY

NCT00996086 - Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) | Biotech Hunter | Biotech Hunter